Prevention of recurrent urinary tract infections in women. Antimicrobial and nonantimicrobial strategies

Infectious Disease Clinics of North America

Volumn 28, Issue 1, 2014, Pages 135-147

  Geerlings, Suzanne E ^a   Beerepoot, Mariëlle A J ^a   Prins, Jan M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Antimicrobial prophylaxis; Cranberries; Lactobacilli; Methenamine; Non antimicrobial strategies; Recurrent urinary tract infections

Indexed keywords

ANTIMICROBIAL PROPHYLAXIS; CRANBERRIES; LACTOBACILLI; METHENAMINE; NON-ANTIMICROBIAL STRATEGIES; RECURRENT URINARY TRACT INFECTIONS;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ASCORBIC ACID; BACTERIAL VACCINES; ESTROGENS; FEMALE; HUMANS; LACTOBACILLUS; RECURRENCE; SELF CARE; URINARY TRACT INFECTIONS;

EID: 84895074747     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2013.10.001     Document Type: Review

References (38)

1. Albert X., Huertas I., Pereiro I.I., et al. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004, (3). CD001209.
2. Gupta K., Hooton T.M., Roberts P.L., et al. Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med 2001, 135(1):9-16.
3. van Haarst E.P., van A.G., Heldeweg E.A., et al. Evaluation of the diagnostic workup in young women referred for recurrent lower urinary tract infections. Urology 2001, 57(6):1068-1072.
4. Melekos M.D., Asbach H.W., Gerharz E., et al. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol 1997, 157(3):935-939.
5. Rudenko N., Dorofeyev A. Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study. Arzneimittelforschung 2005, 55(7):420-427.
6. Schaeffer A.J., Stuppy B.A. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. J Urol 1999, 161(1):207-211.
7. Zhong Y.H., Fang Y., Zhou J.Z., et al. Effectiveness and safety of patientinitiated single-dose versus continuous low-dose antibiotic prophylaxis for recurrent urinary tract infections in postmenopausal women: a randomized controlled study. J Int Med Res 2011, 39(6):2335-2343.
8. Beerepoot M.A., ter R.G., Nys S., et al. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. Arch Intern Med 2011, 171(14):1270-1278.
9. Beerepoot M.A., ter R.G., Nys S., et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med 2012, 172(9):704-712.
10. Castello T., Girona L., Gomez M.R., et al. The possible value of ascorbic acid as a prophylactic agent for urinary tract infection. Spinal Cord 1996, 34(10):592-593.
11. Ochoa-Brust G.J., Fernandez A.R., Villanueva-Ruiz G.J., et al. Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy. Acta Obstet Gynecol Scand 2007, 86(7):783-787.
12. Howell A.B., Botto H., Combescure C., et al. Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis 2010, 10:94.
13. Kontiokari T., Sundqvist K., Nuutinen M., et al. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001, 322(7302):1571.
14. Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol 2002, 9(3):1558-1562.
15. Jepson R.G., Craig J.C. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2008, (1). CD001321.
16. Barbosa-Cesnik C., Brown M.B., Buxton M., et al. Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial. Clin Infect Dis 2011, 52(1):23-30.
17. McMurdo M.E., Argo I., Phillips G., et al. Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women. J Antimicrob Chemother 2009, 63(2):389-395.
18. Stapleton A.E., Dziura J., Hooton T.M., et al. Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial. Mayo Clin Proc 2012, 87(2):143-150.
19. Perrotta C., Aznar M., Mejia R., et al. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2008, (2). CD005131.
20. Raz R., Stamm W.E. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993, 329(11):753-756.
21. Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999, 180(5):1072-1079.
22. Raz R., Colodner R., Rohana Y., et al. Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. Clin Infect Dis 2003, 36(11):1362-1368.
23. Falagas M.E., Betsi G.I., Tokas T., et al. Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies. Drugs 2006, 66(9):1253-1261.
24. Baerheim A., Larsen E., Digranes A. Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scand J Prim Health Care 1994, 12(4):239-243.
25. Stapleton A.E., Au-Yeung M., Hooton T.M., et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis 2011, 52(10):1212-1217.
26. Lee B.B., Simpson J.M., Craig J.C., et al. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev 2007, (4). CD003265.
27. Lee B.S., Bhuta T., Simpson J.M., et al. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev 2012, (10). CD003265.
28. Naber K.G., Cho Y.H., Matsumoto T., et al. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents 2009, 33(2):111-119.
29. Tammen H. Immunobiotherapy with Uro-Vaxom in recurrent urinary tract infection. The German Urinary Tract Infection Study Group. Br J Urol 1990, 65(1):6-9.
30. Schulman C.C., Corbusier A., Michiels H., et al. Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study. J Urol 1993, 150(3):917-921.
31. Magasi P., Panovics J., Illes A., et al. Uro-Vaxom and the management of recurrent urinary tract infection in adults: a randomized multicenter double-blind trial. Eur Urol 1994, 26(2):137-140.
32. Bauer H.W., Alloussi S., Egger G., et al. A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections. Eur Urol 2005, 47(4):542-548.
33. Hopkins W.J., Elkahwaji J., Beierle L.M., et al. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial. J Urol 2007, 177(4):1349-1353.
34. Uehling D.T., Hopkins W.J., Balish E., et al. Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial. J Urol 1997, 157(6):2049-2052.
35. Uehling D.T., Hopkins W.J., Elkahwaji J.E., et al. Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections. J Urol 2003, 170(3):867-869.
36. Gupta K., Hooton T.M., Naber K.G., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011, 52(5):e103-e120.
37. Mavromanolakis E., Maraki S., Samonis G., et al. Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections. J Chemother 1997, 9(3):203-207.
38. Trautner B.W., Gupta K. The advantages of second best: comment on "Lactobacilli vs antibiotics to prevent urinary tract infections". Arch Intern Med 2012, 172(9):712-714.